Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma

Fig. 2

The relationship between CTCs number and therapeutic efficacy in NPC. a. CTCs number in 12 NPC patients decreased from 8.8 ± 13.1 (before treatment) to 4.3 ± 7.2 (after treatment) following 2 to 4 cycles of chemotherapy. b. CTCs number in patients with PR decreased from 10.8 ± 14.8 (before treatment) to 4.7 ± 8.3 (after treatment). c. CTCs number in PD/SD patients increased from 2.7 ± 1.5 (before treatment) to 3.0 ± 1.7 (after treatment). * P < 0.05

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us